Evidence map›Paper›PMID 12412739›Full record

ReviewClinical and experimental immunology1989

The current status of neutrophil cytoplasmic antibodies.

F J van der Woude, M R Daha, L A van Es

Abstract readReview
In one paragraph

Review in Clinical and experimental immunology, 1989. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The role of cellular immunity in systemic vasculitis.Clinical and experimental immunology · 1995
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Distinction between antinuclear antibody and P-ANCA.Journal of clinical pathology · 1991
    Article
  18. Clinical immunology.Postgraduate medical journal · 1991
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

F J van der WoudeDepartment of Nephrology, State University of Leiden, The Netherlands.
M R Daha
L A van Es

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies in the past 10 years have demonstrated the occurrence of autoantibodies against cytoplasmic constituents in patients with vasculitis and glomerulonephritis. In this review the nomenclature of these antibodies is discussed and assays and clinical associations are summarized. Although the antigens involved are not completely identified, antibodies and T cells reactive with myeloid lysozomal enzymes may both play a significant role in pathogenesis.

Indexed as

Antibodies, Antineutrophil CytoplasmicAutoantigensGlomerulonephritisHumansImmunoassayModels, ImmunologicalTerminology as TopicVasculitisAntibodies, Antineutrophil CytoplasmicAutoantigens

Identifiers

PMID12412739
PMCPMC1534659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.